Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    17531401 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Docetaxel, Androgen Deprivation and Proton Therapy for High Risk Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: < 15% risk of + LN;   Radiation: > 15% risk of + LN
2 Active, not recruiting Radiation Therapy and Hormone Therapy in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
Interventions: Drug: flutamide;   Drug: goserelin acetate;   Radiation: low-LET photon therapy

Indicates status has not been verified in more than two years